Kiora Pharmaceuticals Inc... (KPRX)

AI Score

Unlock

2.83

0.02 (0.71%)

At close: Apr 03, 2025, 3:59 PM

2.92

3.08%

After-hours: Apr 03, 2025, 07:24 PM EDT

Dividends

No dividend history available for Kiora Pharmaceuticals Inc..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Related Stocks

Company	Dividend Yield

Dividend Rankings

KPRX News

1 week ago · Kiora Pharmaceuticals Reports 2024 Results; Retinal Disease Drug Development Pipeline Continues to Advance; Cash and Short-Term Investments Expected to Fund Operations into 2027 - newsfilecorp.com
3 weeks ago · Kiora Pharmaceuticals to Present Preclinical Data on KIO-104 for the Treatment of Proliferative Vitreoretinopathy at the ARVO 2025 Annual Meeting - newsfilecorp.com
1 month ago · Kiora Pharmaceuticals Secures U.S. Composition-of-Matter Patent Expanding Protection of Its Anti-Inflammatory Compound KIO-104 - newsfilecorp.com
1 month ago · Kiora Receives Approval to Initiate KLARITY, a Phase 2 Clinical Trial of KIO-104 for the Treatment of Retinal Macular Edema - newsfilecorp.com